Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
31.23
+0.23 (0.74%)
At close: Sep 16, 2025, 4:00 PM EDT
30.55
-0.68 (-2.18%)
After-hours: Sep 16, 2025, 5:56 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.05 billion as of September 16, 2025. Its market cap has decreased by -53.68% in one year.
Market Cap
4.05B
Enterprise Value
2.48B
1-Year Change
-53.68%
Ranking
Category
Stock Price
$31.23
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.05B, an increase of 193.80%. That is a compound annual growth rate of 22.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 4.02B | -60.55% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.89B |
| Johnson & Johnson | 426.49B |
| AbbVie | 379.81B |
| UnitedHealth Group | 316.00B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 229.39B |